dc.contributor.author | AK, NAZİYE | |
dc.date.accessioned | 2021-03-05T17:49:16Z | |
dc.date.available | 2021-03-05T17:49:16Z | |
dc.identifier.citation | AK N., "THE ROLE ADJUVANT CHEMOTHERAPY IN
RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS:
A TURKISH ONCOLOGY GROUP STUDY", World Conferrence of Lung Cancer 2019, Barcelona, İspanya, 7 - 10 Eylül 2019, ss.933-934 | |
dc.identifier.other | av_c761e707-03d2-402c-98b3-fa8909bbf4eb | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/132165 | |
dc.identifier.uri | https://wclc2019.iaslc.org/wp-content/uploads/2019/08/WCLC2019-Abstract-Book_web-friendly.pdf | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | THE ROLE ADJUVANT CHEMOTHERAPY IN
RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS:
A TURKISH ONCOLOGY GROUP STUDY | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Tıbbi Onkoloji | |
dc.contributor.firstauthorID | 428961 | |